Stocks TelegraphStocks Telegraph
Stock Ideas

ZYME Financial Statements and Analysis

NASDAQ : ZYME

Zymeworks

$24.04
-1.06-4.22%
At Close 4:00 PM
60.77
BESG ScoreESG Rating

FINANCIAL STATEMENTS

An instrumental part of fundamental analysis is measuring key indicators of an asset, which are the factors that can influence its value and price. However, sometimes investors show more interest in financial statements with other factors to determine whether investing in that company is the right decision. Financial statements of a company include:

  • Balance Sheet
  • Income Statement
  • Cash Flow Statement

Income Statement

A company's income statement helps investors and business owners determine whether the company is profitable or losing money. Profitability is a key factor investors consider before investing in a stock. Income statements provide them with information about a company's profitability over time. The statement also enables them to observe trends in company spending and earnings since it breaks down individual costs and revenues. Income statements also provide details on where a company's money is going when it isn't profitable or its profits fluctuate.

DateMar 31, 2026Sep 30, 2025Jun 30, 2025Mar 31, 2025Sep 30, 2024
reported currencyUSDUSDUSDUSDUSD
calendar year20262025202520252024
periodQ1Q3Q2Q1Q3
revenue2.408M27.614M48.726M27.11M16.00M
cost of revenue2.847M0002.663M
gross profit-439.00K27.614M48.726M27.11M13.337M
gross profit ratio-0.1821.001.001.000.834
research and development expenses2.408B35.578M34.449M35.738M36.353M
general and administrative expenses15.069B14.10M14.90M17.00M13.90M
selling and marketing expenses00000
selling general and administrative expenses15.069B14.10M14.90M17.00M13.90M
other expenses-17.43B46.00K51.00K-15.00K-2.711M
operating expenses46.679M49.724M49.40M52.723M47.542M
cost and expenses49.526M49.724M49.40M52.723M50.205M
interest income2.711M3.529M3.426M3.424M4.785M
interest expense2.066M0000
depreciation and amortization2.847M2.584M3.214M3.305M2.663M
ebitda-44.271M-15.682M2.591M-22.323M-26.961M
ebitda ratio-18.385-0.5680.053-0.823-1.685
operating income-47.118M-22.11M-674.00K-25.613M-34.205M
operating income ratio-19.567-0.801-0.014-0.945-2.138
total other income expenses net765.00K3.844M2.805M3.473M4.581M
income before tax-46.353M-18.266M2.131M-22.14M-29.624M
income before tax ratio-19.25-0.6610.044-0.817-1.852
income tax expense-2.191M1.336M-186.00K496.00K226.00K
net income-44.162M-19.602M2.317M-22.636M-29.85M
net income ratio-18.34-0.710.048-0.835-1.866
eps-0.59-0.260.031-0.30-0.39
eps diluted-0.59-0.260.03-0.30-0.39
weighted average shs out74.669M75.768M75.337M75.171M76.129M
weighted average shs out dil74.695M75.775M77.378M75.226M76.157M
Graph

Balance Sheet

Balance sheet summarizes a company's financials and can be used as a basis by investors to determine the value of a company. It shows the value of the stock, as well as the assets and liabilities of the company. A company's balance sheet displays how its assets are put to use and how those assets are financed, based on the liabilities section. Both investors and analysts analyze a company's balance sheet to determine how it allocates its resources.

DateMar 31, 2026Sep 30, 2025Jun 30, 2025Mar 31, 2025Sep 30, 2024
reported currencyUSDUSDUSDUSDUSD
calendar year20262025202520252024
periodQ1Q3Q2Q1Q3
cash and cash equivalents244.282M64.834M98.253M76.204M122.356M
short term investments120.445M187.099M183.126M189.083M174.844M
cash and short term investments364.727M251.933M281.379M265.287M297.20M
net receivables4.674M29.352M2.631M24.594M23.704M
inventory00000
other current assets16.279M10.427M12.12M16.586M22.865M
total current assets385.68M291.712M296.13M306.467M343.769M
property plant equipment net28.87M32.467M32.574M33.408M35.688M
goodwill12.016M12.016M12.016M12.016M12.016M
intangible assets1.174M1.397M2.045M3.362M6.578M
goodwill and intangible assets13.19M13.413M14.061M15.378M18.594M
long term investments39.116M47.427M51.996M56.324M77.667M
tax assets4.707M4.862M4.769M4.849M4.206M
other non current assets6.652M7.388M8.855M9.096M7.228M
total non current assets92.535M105.557M112.255M119.055M143.383M
other assets00001.00
total assets478.215M397.269M408.385M425.522M487.152M
account payables30.226M1.305M32.00K5.223M3.423M
short term debt3.279M3.40M3.586M3.258M2.943M
tax payables66.00K0112.00K132.00K2.071M
deferred revenue2.078M3.197M3.811M23.495M27.188B
other current liabilities034.141M30.961M32.995M56.713B
total current liabilities35.649M42.043M38.502M65.103M83.909B
long term debt13.763M15.504M15.092M15.202M32.794B
deferred revenue non current14.606M14.607M14.607M14.607M14.607M
deferred tax liabilities non current3.827M4.773M4.85M4.815M3.455B
other non current liabilities246.781M278.00K828.00K828.00K32.778B
total non current liabilities278.977M35.162M35.377M35.452M36.265B
other liabilities0000-120.054B
capital lease obligations17.042M018.678M18.46M20.25M
total liabilities314.626M77.205M73.879M100.555M120.174M
preferred stock00000
common stock1.136B1.101B1.082B1.03B1.023B
retained earnings-1.074B-886.472M-850.654M-852.971M-797.834M
accumulated other comprehensive income loss-6.565M-6.05M-6.34M-6.406M-5.999M
other total stockholders equity107.53M111.489M109.243M154.216M148.296M
total stockholders equity163.589M320.064M334.506M324.967M366.978M
total equity163.589M320.064M334.506M324.967M366.978M
total liabilities and stockholders equity478.215M397.269M408.385M425.522M487.152M
minority interest00000
total investments159.561M234.526M235.122M245.407M252.511M
total debt17.042M18.904M18.678M18.46M20.25M
net debt-227.24M-45.93M-79.575M-57.744M-102.106M
Graph

Cash Flow

A cash flow statement is regarded as a valuable indicator of profitability and the long-term outlook for a company. It assists the company in evaluating whether it has sufficient funds to cover its expenses. Essentially, a cash flow statement represents an organization's financial health. The cash flow statement, which measures the business's ability to operate in the short as well as long term, is broken down into operating, investing, and financing activities.

DateMar 31, 2026Sep 30, 2025Jun 30, 2025Mar 31, 2025Sep 30, 2024
reported currencyUSDUSDUSDUSDUSD
calendar year20262025202520252024
periodQ1Q3Q2Q1Q3
deferred income tax-220.00K-170.00K115.00K-410.00K-435.77M
stock based compensation6.935M6.911M5.871M6.402M12.763B
change in working capital-10.873M-20.684M-154.00K9.964M20.574M
accounts receivables-36.00K-26.721M21.989M31.219M-4.716B
inventory00000
accounts payables-7.75M3.341M-7.105M-21.219M6.997B
other working capital-3.087M2.696M-15.038M-36.00K7.297M
other non cash items-245.00K-451.00K710.00K-32.00K12.618B
net cash provided by operating activities-45.718M-31.412M12.073M-3.407M-68.474B
investments in property plant and equipment-216.00K-410.00K-514.00K-16.00K1.738M
acquisitions net00000
purchases of investments0-35.054M-70.147M-34.032M-229.747B
sales maturities of investments70.175M35.832M79.776M46.552M-150.625M
other investing activites00-370.00K-322.00K274.893B
net cash used for investing activites69.959M368.00K8.745M12.182M44.997B
debt repayment245.613M000-8.936K
common stock issued9.324M01.433M0-3.239M
common stock repurchased-76.151M000929.614M
dividends paid00000
other financing activites0-2.452M-114.288K1.316M-12.738B
net cash used provided by financing activities178.786M-2.452M1.319M1.316M-11.811B
effect of forex changes on cash98.00K77.00K-88.00K10.00K172.819M
net change in cash203.125M-33.419M22.049M10.101M122.285B
cash at end of period244.282M64.834M98.253M76.204M122.356B
cash at beginning of period41.157M98.253M76.204M66.103M70.963M
operating cashflow-45.718M-31.412M12.073M-3.407M-68.474B
capital expenditure-216.00K-410.00K-884.00K-338.00K1.738M
free cash flow-45.718M-31.822M11.189M-3.745M-68.472B
Graph

Frequently Asked Questions

How did Zymeworks Inc. do last quarter? What was its Total Revenue and Cost of Revenue?
A company's Total Revenue reveals how much money it generates before any expenses or deductions are made. As a result, this metric informs investors/stakeholders how much money the business makes. Tracking and understanding it is essential for evaluating a company's growth. As opposed to revenue, Cost of Revenue is any expenses a business incur to generate revenue. There can be high revenue in a business, but if the costs are high, it won't make a profit and will go out of business when money runs out. Therefore, ZYME generated $2.41M in revenue last quarter, while its costs came in at $2.85M.
Last quarter, how much Gross Profit did Zymeworks Inc. report?
A business's Gross Profit is a key indicator of its profitability and financial performance. In other words, it reflects how efficiently a business uses labor, raw materials, and other resources. Zymeworks Inc. reported a -$439.00K Gross Profit for the quarter ended Mar 31, 2026.
Have ZYME's Total Operating Expenses and Operating Income been favorable recently?
Operational Expenses represent the costs a company must incur to generate revenue, which is the ultimate goal of a business, whereas Operating Income shows the revenue left after operational direct and indirect costs have been deducted. ZYME incurred $46.68M worth of Operating Expenses, while it generated -$47.12M worth of Operating Income.
How much Net Income has ZYME posted recently?
The Net Income of a company is one of the factors investors consider when investing in the company. According to recent earnings report from Zymeworks Inc., the company generated -$44.16M in Net Income. When a company has a history of consistent net income, investors are more likely to invest in it since they know they will get a return.
At the end of the last quarter, how much Cash and Equivalents did Zymeworks Inc. have?
The amount of Cash and Cash Equivalents is an effective indicator of the financial strength and well-being of a company. An excess cash situation occurs when a company has more cash and cash equivalents than it needs for operating activities. The amount of Cash and Cash Equivalents available to Zymeworks Inc. as of the end of the last quarter was $244.28M.
What are ZYME's Total Net Receivables for the last quarter?
Total Net Receivables are a company's outstanding debts to its customers. Therefore, it refers to the amount that a company expects to collect from its customers. The higher a company's net receivables are, the more confident it is that it can collect money from its debtors. As of the end of the last quarter, ZYME had Total Net Receivables of $4.67M.
In terms of Total Assets and Current Assets, where did Zymeworks Inc. stand at?
An asset with an economic value within a year is considered a current asset. Total assets, however, also include long-term fixed assets, intangible assets, and other non-current assets. The current Assets of ZYME were $385.68M, while the Total Assets stand at $478.22M.
As of the last quarter, how much Total Debt did Zymeworks Inc. have?
The total debt of a business refers to how much it borrows. A company's current and long-term liabilities are added together to calculate its Total Debt. A debt ratio may be taken into account on a balance sheet by financial lenders, investors, and business leaders when making informed decisions about future loans or investments. The total amount of ZYME's debt was $17.04M at the end of the last quarter.
What were ZYME's Total Liabilities during the last reported quarter?
A company's total liabilities are the sum of all debts it is liable for, including any off-balance shee liabilities it may incur. This can be calculated by adding up all short-term and long-term liabilities. In its last quarter, ZYME reported total liabilities of $314.63M.
How much did ZYME's Working Capital change over the last quarter?
Working Capital Change for ZYME was -$10.87M over the last quarter. Working Capital Change refers to the difference between net working capital amounts at the end of one accounting period and the end of another. It tells investors/stakeholders how much the company's cash flow will differ from its Net Income (i.e., after-tax profits). More powerful companies often have positive Change in Working Capital numbers as they have increased control over collecting cash from customers and delaying payments to suppliers.
ZYME generated how much cash from operating activities?
An operating cash flow statement usually contains cash from operating activities in the first section. An organization's cash from operating activities refers to the money it takes in and takes out as a result of its regular business operations. ZYME generated -$45.72M of Cash from Operating Activities during its recently reported quarter.
What was ZYME's latest reported Net Change in Cash?
An increase or decrease in cash and cash equivalent balances within a specified period is considered the net change in cash in a cash flow statement. Furthermore, it takes into account cash changes as a result of investments, financing, and operating activities. ZYME reported a $203.13M Net Change in Cash in the most recent quarter.
logo

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

© 2026 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep

stockstelegraph

Don't have an account?

stockstelegraph

Don't have an account?

stockstelegraph

Already have an account?

stockstelegraph
Smart Screening Tools for Exceptional Returns
stockstelegraph

For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market. Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.

Ready to Win Big?

Try Now for Just $1!
stockstelegraph